United States · FDA National Drug Code directory
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70752-141_be5ec0f7-35dc-4a88-af15-45c70c44be08
- Product NDC
- 70752-141
- Form
- CAPSULE
- Composition / generic term
- BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
- Labeler
- QUAGEN PHARMACEUTICALS LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220806
- Source listing expiry
- 20261231
Source-listed ingredients
- BUTALBITAL — 50 mg/1
- ACETAMINOPHEN — 325 mg/1
- CAFFEINE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE, PLASTIC (70752-141-10) · 70752-141-10
- 500 CAPSULE in 1 BOTTLE, PLASTIC (70752-141-14) · 70752-141-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →